Penumbra (PEN) Change in Accured Expenses (2014 - 2026)
Penumbra (PEN) posted quarterly Change in Accured Expenses of $17.8 million for Q2 2026, up 260.75% year-over-year from $4.9 million in Q2 2025, and up 5.14% quarter-over-quarter from $16.9 million in Q1 2026.
Penumbra (PEN) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Change in Accured Expenses for 13 consecutive years, with $17.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Accured Expenses rose 260.75% year-over-year to $17.8 million; the TTM figure through Jun 2026 stood at $42.2 million (up 105.59% YoY), while the FY2025 annual figure was $12.9 million, down 8.16% from the prior year.
- Change in Accured Expenses grew to $17.8 million in Q2 2026 per PEN's latest filing, from $16.9 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $17.8 million in Q2 2026 and bottomed at -$9.5 million in Q3 2022.
- Historically, Change in Accured Expenses has averaged $4.4 million across 5 years, with a median of $3.2 million in 2022.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 298.47% — and 2025, when it soared 5575.86%.
- Penumbra's Change in Accured Expenses stood at $4.4 million in 2022, then surged by 50.15% to $6.6 million in 2023, then jumped by 111.4% to $13.9 million in 2024, then plunged by 85.06% to $2.1 million in 2025, then jumped by 758.09% to $17.8 million in 2026.
- Business Quant data shows PEN's Change in Accured Expenses at $17.8 million in Q2 2026, $16.9 million in Q1 2026, and $2.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Penumbra | 12.78 Bn | 12.13 Bn | 264.94 Mn | 17.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.81 Mn |
| Jun 30, 2026 | 17.81 Mn |
| Mar 31, 2026 | 16.94 Mn |
| Mar 31, 2026 | 16.94 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Mar 31, 2025 | 574,000.00 |
| Mar 31, 2025 | 574,000.00 |
| Dec 31, 2024 | 13.89 Mn |
| Dec 31, 2024 | 13.89 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | -1.02 Mn |
| Mar 31, 2024 | -1.02 Mn |